AstraZeneca is paying $160 million for FibroGen’s China business, giving the U.K.-based Big Pharma the regional rights to ...

Zealand’s CEO Adam Steensberg said that the company is “exactly where it wants to be” in terms of its partnering and ...

In this edition of “Psychedelic”, The Fly conducted an exclusive interview with Joseph Tucker, Chief Executive Officer and Director of Enveric ...

Krupacon 2025 underscores technology, acumen, green initiatives to pave the future of pharma: Nandita Vijayasimha, Bengaluru Friday, February 21, 2025, 08:00 Hrs [IST] The future ...

We recently published a list of the 12 Most Oversold Healthcare Stocks to Buy Now. In this article, we are going to take a ...

Mike Judge's ride is a drug-fueled, spy-driven frolic through moral hangups and philosophical dives, just like Rick and Morty ...

"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...

From turning away inspectors to falsifying data and leaving "bare footprints" in production containers, two of the latest ...

On The Readout LOUD this week, STAT reporters discuss the FDA's staff cuts, how next-gen drugs may lead to too much weight ...

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.